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Abstract
Pulmonary hemorrhage has been recognized as a major, often lethal, manifestation of severe leptospirosis albeit the
pathogenesis remains unclear. The Leptospira interrogans virulent serogroup Icterohaemorrhagiae serovar Lai encodes a
protein (LA2144), which exhibited the platelet-activating factor acetylhydrolase (PAF-AH) activity in vitro similar to that of
human serum with respect to its substrate affinity and specificity and thus designated L-PAF-AH. On the other hand, the
primary amino acid sequence of L-PAF-AH is homologous to the a1-subunit of the bovine brain PAF-AH isoform I. The L-
PAF-AH was proven to be an intracellular protein, which was encoded unanimously and expressed similarly in either
pathogenic or saprophytic leptospires. Mongolian gerbil is an appropriate experimental model to study the PAF-AH level in
serum with its basal activity level comparable to that of human while elevated directly associated with the course of
pulmonary hemorrhage during severe leptospirosis. Mortality occurred around the peak of pulmonary hemorrhage, along
with the transition of the PAF-AH activity level in serum, from the increasing phase to the final decreasing phase. Limited
clinical data indicated that the serum activity of PAF-AH was likely to be elevated in the patients infected by L. interrogans
serogroup Icterohaemorrhagiae, but not in those infected by other less severe serogroups. Although L-PAF-AH might be
released into the micro-environment via cell lysis, its PAF-AH activity apparently contributed little to this elevation.
Therefore, the change of PAF-AH in serum not only may be influential for pulmonary hemorrhage, but also seems suitable
for disease monitoring to ensure prompt clinical treatment, which is critical for reducing the mortality of severe
leptospirosis.
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Introduction
Leptospirosis continues to be a leading zoonotic infection
throughout the world [1]. Pathogenic leptospires infection caused
a diverse array of clinical manifestations ranging from subclinical
infection to undifferentiated febrile illness to jaundice, renal
failure, and potentially lethal pulmonary hemorrhage [2,3].
Pulmonary hemorrhage is the most frequent cause of death of
leptospirosis [4–6].
So far, lipopolysaccharide (LPS) [7,8], glycolipoprotein [9,10],
peptidoglycan [11], hemolysin [12], and other virulent factorshave
been considered contributing to the leptospira’s pathogenicity.
However, little is known about the substances and mechanisms
responsible for the hemorrhage and hemoptysis involved in their
pathogenicity. It is generally believed that neither thrombocytopenia
nor diminution of hepatically synthesized clotting factors seen in
human leptospirosis were sufficient to account for the bleeding
diathesis observed per se [1–3]. In 2004, Nally et al. reported that an
autoimmune process may be involved in the etiology of fatal
pulmonary hemorrhage in leptospirosis [13].
Based on the annotation of Leptospira interrogans’ genomic
sequence (serovar Lai strain 56601) [14], we recognized that the
open reading frame (ORF) of la2144 in the bacterial chromosome
I seems encoding a putative platelet-activating factor acetylhy-
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4181drolase (PAF-AH). Its primary amino acid sequence exhibited
significant levels of similarity to the a1-subunit of bovine brain
PAF-AH isoform I (EC 3.1.1.47), a 29-kDa protein isolated from
bovine brain soluble fraction [15–17]. PAF-AH isoform I is an
intracellular heterotrimeric enzyme composed of three subunits
with molecular mass of 29- (a1), 30- (a2), and 45-kDa (b)
respectively. Both a1 and a2 are catalytic subunits, but the a1
alone is sufficient to catalyze the removal of the acetyl moiety at
the sn-2 position of PAF to generate the biologically inactive lyso-
PAF [17]. Thus, LA2144 might hydrolyse PAF through its PAF-
AH activity, and it was speculated to be associated with the
pulmonary hemorrhage during severe leptospirosis.
Here, the identification and biochemical characterization of this
leptospiral PAF-AH is firstly reported. By experimental infection
to a Mongolian gerbil model, we found that although leptospiral
PAF-AH contributed little to the change of PAF-AH level in gerbil
sera during severe leptospirosis, the PAF-AH levels in serum were
elevated along with the development of clinical manifestation,
particularly, the whole course of pulmonary hemorrhage.
Results
The LA2144 is homologous to the PAF-AH isoform I a1-
subunit
Deduced amino acid sequence of ORF LA2144 (amino acid
residues 23–248) of L. interrogans serovar Lai was highly
homologous (23% identity and 42% similarity) to that of the a1-
subunit of PAF-AH isoform I (Figure 1). The a1 subunit of PAF-
AH isoform I contains an essential serine residue within a motif
which was perfectly conserved in LA2144 (Gly
78-Asp
79-Ser
80-
Leu
81-Ile
82). Besides, other two essential His
224 and Asp
227
residues were also conserved in LA2144, which may form a
catalytic triad with Ser
80 as in a1 (Figure 1). It thus suggested that
LA2144 might have an ‘‘a1-subunit-like’’ function despite its
unique N-terminal 22 residues (Figure 1) and the gene encoding
LA2144 was thus tentatively designated l-paf-ah for leptospiral
platelet-activating factor acetylhydrolase [14].
The heterogeneously expressed L-PAF-AH demonstrated
PAF-AH activity similar to that in the human serum
The l-paf-ah gene, with its original 66 nucleotides deleted from
59 end, was cloned with an N-terminal His-tag fusion and
expressed in Escherichia coli and then purified to homogeneity
indicated by SDS-PAGE (Figure S1). The PAF-AH activity of the
recombinant His-tag-L-PAF-AH protein (rL-PAF-AH) was as-
sayed by employing the PAF artificial substrate [1-myristoyl-2-(4-
nitrophenyl succinyl) phosphatidylcholine]. The kinetic parame-
ters of the purified rL-PAF-AH was determined (Table 1) with its
specific activity being 13.91 IU/mg (kcat=6.61 s
21). Meanwhile,
the Km of the human serum PAF-AH towards the artificial
substrate was found to be 0.27 mM assayed by the same
methodology (Table 1), which is in the same order of magnitude
with that of the rL-PAF-AH (0.61 mM).
L-PAF-AH is a cytosolic protein
Since the N-terminal (residues 1–22) of L-PAF-AH was
predicted as a signal peptide (Figure 1), we tried to examine
whether the L-PAF-AH was located on the surface of the cell. We
failed to detect any PAF-AH activities by examining the resting
live cells of L. interrogans serovar Lai strain 56601 although it was
readily detected in the crude cell extracts (unpublished data).
Therefore, the L-PAF-AH is unlikely an enzyme located outside of
the cell.
We also tried to examine whether the L-PAF-AH in L. interrogans
serovar Lai strain 56601 was secreted into the medium.
Leptospiral culture of strain 56601 in EMJH medium was initiated
with 10% inoculation of a mid-log-phase pre-culture and
incubated under 28uC with gentle shaking. Aliquot samples of
the culture were collected at various time points (0, 30, 54, 78, 94,
103, and 130 hr) over the incubation period up to the stationary
Figure 1. Alignment of the amino acid sequences of LA2144 and bovine PAF-AH isoform I a1-subunit. The alignment was generated by
using ClustalW. Identical and similar amino acids were shaded. Identical amino acids were indicated by asterisks. The conserved motif Gly-Asp-Ser-
Leu-Val/Ile, and the enzyme activity sites, Asp and His, were indicated in purple. Hypothetical signal peptide was boxed. Tyr
195 of LA2144 was marked
in red, and its relative amino acid at bovine PAF-AH isoform I a1-subunit was indicated in blue.
doi:10.1371/journal.pone.0004181.g001
Table 1. Kinetic parameters of rL-PAF-AH, human serum and
the specific activity of Y195H rL-PAF-AH.
Enzyme
Km
(mM)
kcat
(s
21)
kcat/Km
(mM
21 s
21)
Specific activity
(IU/mg)
rL-PAF-AH 0.61 6.61 10.84 13.91
Human serum 0.27
Y195H rL-PAF-AH 12.79
All values represented means of results from duplicate experiments.
doi:10.1371/journal.pone.0004181.t001
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were concentrated by lyophilization and examined by ELISA with
anti-L-PAF-AH specific antibodies. The assay indicated that L-
PAF-AH in the media was not detected until entering the early-
stationary phase (103 hr) when bacterial cell lysis was observed
(Figure 2). The concentration of L-PAF-AH in the media
increased in the later stationary phase as more cells were lysed
(130 hr) (Figure 2).
Employing the anti-L-PAF-AH specific antibodies, the L-PAF-
AH protein was immunoprecipitated from both the cell crude
extract of L. interrogans serovar Lai strain 56601 cultured in EMJH
media and the culture supernatant from the same sample and then
examined by mass spectrometry. L-PAF-AH was identified in the
cytosolic fractions from samples collected at both the 54
th hr (log
phase) and the 130
th hr (stationary phase) (Figure 2). However, it
was only detected in the medium supernatant of the 130
th hr
sample, but not in that of the 54
th hr sample. These results clearly
demonstrated that L-PAF-AH is an intracellular protein, which is
not released into the culture medium until the bacterial cells were
autolysed.
The l-paf-ah gene is present unanimously and expressed
similarly in either pathogenic or saprophytic leptospires
Nine standard strains of different serovars commonly found in
China and the avirulent strain of L. interrogans serovar Lai (Table 2)
were selected to analyze their l-paf-ah gene including their
probable promoter regions via PCR amplification followed by
sequencing confirmation. The results indicated that the l-paf-ah
gene is unanimously present in these strains with limited genetic
variations. There was only one asynonymou single nucleotide
variation (SNV) causing the Y195H amino acid switch (Table 2)
found in the l-paf-ah gene out of maximal 8 SNVs from four
leptospires (Figure S2). The recombinant Y195H L-PAF-AH
(Y195H rL-PAF-AH) was able to hydrolyze PAF, and its specific
activity was 12.79 IU/mg, similar to that of the L-PAF-AH from
strain 56601 (Table 1).
For expression patterns, the l-paf-ah mRNAs were detected in all
of the ten leptospira strains grown in EMJH and Korthof media via
RT-PCR (Table 2). We also determined the specific activity in the
cell crude extracts. As shown in Table 2, the specific activities were
similar among ten pathogenic and saprophytic leptospires cultured
in EMJH or Korthof media. These results demonstrated that L-
PAF-AHs are conserved in both their primary structure and the
expression patterns in eight pathogenic leptospires and the two
saprophytic leptospires.
Mongolian gerbil as the experimental model for
analyzing serum PAF-AH related symptoms
Among the various animal species used for experimental studies
of leptospirosis, Mongolian gerbil [18,19] has been known for its
lethal infection to leptospira of many serovars with symptoms of
pulmonary hemorrhage. We determined the PAF-AH levels in the
sera of healthy mice (ICR, BALB/c, CBA/N, C57BL/6, DBA/2,
and C3H/HeJ), rats (Fischer 344, Sprague-Dawley, and Wistar),
golden hamster, guinea pig, Mongolian gerbil, and New Zealand
Figure 2. As an intracellular protein, L-PAF-AH was released
into the culture medium via autolysis when entering the
stationary phase. L. interrogans was grown in EMJH medium. Culture
samples were obtained at 0, 30, 54, 78, 94, 103 and 130 hr, after initial
inoculation. The cell densities (squares) were counted in a Petroff-
Hausser counting chamber (Fisher) while the L-PAF-AH protein
concentrations (triangles) in the culture supernatants were determined
by ELISA. The standard deviations were in all cases below 10%. L-PAF-
AH protein was further detected in selected cells crude extracts and
culture supernatants (w, q, &) by mass spectrometry. w, identified in
culture supernatants; q, not identified in culture supernatants; &,
identified in cells crude extracts.
doi:10.1371/journal.pone.0004181.g002
Table 2. The amino acid
195, RT-PCR and specific activity of PAF-AH in ten leptospires cultured in EMJH and Korthof media.
Strain Amino acid
195 RT-PCR
a RT-PCR
b
Specific activity
c
(IU/10
10 leptospira)
Specific activity
d (IU/
10
10 leptospira)
L. interrogans serovar Lai strain 56601 Tyr ++0.2260.023 0.460.045
Avirulent variant strain of L. interrogans serovar lai Tyr ++0.1860.015 0.3860.05
L. interrogans serovar Javanica strain M 10 Tyr ++0.2060.021 0.4860.06
L. interrogans serovar Canicola strain Lin His ++0.1560.018 0.4560.06
L. interrogans serovar Pomona strain Luo His ++0.1460.017 0.3560.03
L. interrogans serovar Linhai strain Lin 6 Tyr ++0.1760.023 0.4060.05
L. interrogans serovar Hebdomadis strain P 7 His ++0.2560.03 0.3760.03
L. interrogans serovar Paidjan strain L 37 Tyr ++0.2460.03 0.3460.03
L. biflexa serovar Montevalerio Tyr ++0.2860.025 0.4860.05
L. biflexa serovar Anhui strain Zong 7 His ++0.2160.016 0.4160.06
aRT-PCR detection of l-paf-ah mRNA from leptospires cultured in EMJH medium. +, positive result.
bRT-PCR detection of l-paf-ah mRNA from leptospires cultured in Korthof medium. +, positive result.
cSpecific activity of leptospires cultured in EMJH medium.
dSpecific activity of leptospires cultured in Korthof medium.
doi:10.1371/journal.pone.0004181.t002
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indicated that the enzyme level was stable in healthy gerbils
(Figure 3B), similar to that of human beings (Figure 3A).
Therefore, Mongolian gerbil was selected as the experimental
model.
Mortality of the L. interrogans infected gerbil was
strongly associated with pulmonary hemorrhage
The leptospirosis in gerbil model was designed to study the
association of PAF-AH level in serum and pulmonary hemorrhage
during the whole course of L. interrogans serovar Lai infection
(Figure S3) with an avirulent strain (Figure S4) as the negative
control. Gerbils intraperitoneally injected with the virulent strain
began to show loss of mobility, and general unkemptness from day
2 to day 3, and on the 9
th day, the activities of all survived animals
were back to normal. Animals in the virulent group began to show
pulmonary hemorrhage on day 2 after inoculation, and pulmo-
nary hemorrhage became much more severe on the 5
th day. Then,
pulmonary hemorrhage became less and less severe and totally
returned to normal on the 9
th day (Figure 4A). Dying of the model
animals began to occur on day 4, and the peak of mortality was
observed on the 5
th day (Figure 4B). Autopsy of all animals that
died on day 5 and 6 were shown to bear jaundice and pulmonary
hemorrhage. For animals died on the 4
th,7
th and 8
th day,
pulmonary hemorrhage was the only typical pathological
symptom observed (Figure 4B).
Autopsy of animals sampled from day 1 to day 9 of the PBS
group demonstrated no hemorrhage (Figure 4B). However,
minor pulmonary hemorrhage (Figure 4B) without mortality
(Figure 4A) was observed in gerbils infected by the avirulent
strain from day 2 to day 9, or in gerbils infected by the virulent
strain sampled on day 2 and day 3. These results implicated that
severe pulmonary hemorrhage was strongly associated with the
death of infected models, in other words, all gerbils died with
pulmonary hemorrhage. On the other hand, more gerbils died
during the increasing phase of pulmonary hemorrhage (n=26,
sum for day 4 and day 5) than the decreasing phase (n=15, sum
for day 6 to day 8), and most gerbils (n=18) died on the 5
th day
when the pulmonary hemorrhage was the most severe (Figure 4A
and 4B).
The change of PAF-AH level in serum was directly
associated with the pulmonary hemorrhage
PAF-AH level in serum of the animals injected with the
virulent strain began to increase from day 2, reached the peak on
day 5, and then decreased to normal on the 8
th day and these
elevations were statistically significant (P,0.01) (Figure 4C). In
contrast, there was no significant difference for the PAF-AH level
in sera of groups injected with either the PBS or the avirulent
strain (Figure 4C). The only exception was that on the 4
th and
5
th day, the PAF-AH level in serum of the avirulent strain group
with pulmonary hemorrhage was slightly higher than that of the
PBS group and the avirulent group without pulmonary
hemorrhage. Therefore, PAF-AH level in serum is directly
associated with the pulmonary hemorrhage level along the
course of disease.
PAF-AH assay was also carried out employing serum samples
from some leptospirosis patients. The data shown in Figure 5
indicated that the serum activity of PAF-AH was elevated in the
patients infected by L. interrogans serogroup Icterohaemorrhagiae,
but not in those infected by L. interrogans serogroup Pyrogenes,
Autumnalis, Pomona, Hebdomadis or Canicola. Although more
clinical data are required for proof, it suggested that the change of
PAF-AH activity in patients’ serum might be associated with
different serogroups of the infectious leptospires, which may or
may not lead to the life-threatening pulmonary hemorrhage.
L-PAF-AH contributed little PAF-AH activity to the
increase of PAF-AH level in serum in the severe
leptospirosis
Although L-PAF-AH was identified as an intracellular protein,
it could be released into the blood circulation after leptospira
cells were lysed, and then led to the elevation of PAF-AH level in
serum. We tried to make a rough estimation of L-PAF-AH
released to the serum by measuring its level in an in vitro serum
culture (Korthof medium). The specific activity of L-PAF-AH
from L. interrogans serovar Lai grown in Korthof medium was
approximately 0.4 IU/10
12 leptospires (Table 2). The average
level of PAF-AH in serum from gerbil infected with the virulent
strain was 418.3 IU/L. Therefore, comparing to the 203.7 IU/L
level of the PBS group, the average elevation after infection was
214.6 IU/L. For gerbils with 40 to 70 g of body weight, there
was approximately 5 ml total circling blood [20]. Therefore, if
the L-PAF-AH was the only factor for the elevation of PAF-AH
level in serum, the leptospira density would be 1.1610
12/ml
(5.4610
12 bacteria in 5 ml gerbil circulating blood). However,
the highest leptospira density measured in the gerbil circulating
blood was approximately 4610
8/ml during the course of disease
(Figure 6).
To exclude the possibility of higher level of L-PAF-AH
expression from L. interrogans in gerbils than that cultured in
Korthof medium, anti-L-PAF-AH rabbit polyclonal serum and
murine monoclonal antibodies were used to detect L-PAF-AH in
the sera of gerbils with pulmonary hemorrhage employing both
ELISA and immunoprecipation followed by mass spectrometry.
There was no detectable L-PAF-AH in the 500 ml sera collected
either during the increasing phase for PAF-AH in serum (on the
2
nd,3
rd,4
th,5
th and 6
th days) or during the decreasing phase (on
the 7
th,8
th and 9
th days) (Figure S5). Therefore, L-PAF-AH might
contribute little to the increase of PAF-AH level in serum for the
severe leptospirosis.
Discussion
When L-PAF-AH was firstly recognized by its deduced amino
acid sequence [14] and simulated tertiary structure (unpublished
data) similarity to the a1-subunit of the mammalian PAF-AH
isoform I via the annotation of L. interrogans genome, its enzymatic
activity was identified employing an artificial substrate used for
assaying the serum enzyme [21]. Although, so far, there is no
complete data available for enzyme kinetic parameters of the
serum PAF-AH towards this artificial substrate, its Km was
determined in this study, which is similar to that of the L-PAF-AH.
Therefore, in contrast to the analogous activity found in a
bifunctional CMP-N-acetylneuraminic acid synthetase (CS) en-
coded by a pathogenic E. coli K1 as one of its two catalytic
domains [22], this L-PAF-AH is an independent single-chain
enzyme, with its structure similar to that of the mammalian
isoform I a1-subunit while its substrate specificity being different
from that of the E. coli CS but similar to the serum counterpart
enzyme.
At least three types of PAF-AH have been identified in
mammals, i.e., the intracellular types I and II, and a serum
(plasma) type. The PAF-AH II has its substrate specificity similar
to the serum PAF-AH. Both enzymes can hydrolyze phospholipids
with short to medium length sn-2 acyl chains including truncated
ones derived from oxidative cleavage of long chain polyunsatu-
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PLoS ONE | www.plosone.org 4 January 2009 | Volume 4 | Issue 1 | e4181Figure 3. Serum PAF-AH levels of healthy human individuals and animal species (A), and the serum PAF-AH levels of normal gerbils
(n=6) on the serial 32 days (B). Bars indicated the standard error. w, human or animal species commonly used for experimental study of
leptospirosis.
doi:10.1371/journal.pone.0004181.g003
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succinyl)-phosphatidylcholine [21]. On the other hand, PAF-AH
isoform I hydrolyzes the sn-2 ester bond in PAF-like phospholipids
with a marked preference for very short acyl chains, typically
acetyl. The a1-subunit of PAF-AH isoform I has a strong
preference for acetyl groups attached to the glycerol backbone of
PAF [24], and this specificity is ascertained to the Leu
48, Leu
194
and Thr
103 residues of the enzyme by forming contact with the
methyl group of acetate [17]. The PAF-AH domain of the E. coli
CS is highly similar to the a1-subunit of PAF-AH isoform I with
respect to both its amino acid sequence and the computer
simulated 3-D structure. Thus, it is no surprise that the PAF-AH
domain of the E. coli CS exhibited similar substrate specificity as
that of the a1-subunit [22]. The amino acid residues correspond-
ing to Leu
48, Leu
194 and Thr
103 of the a1-subunit were also
conserved in the E. coli CS (identified as Leu
258, Leu
399 and Thr
308
based on three-dimensional modeling) [22].
In contrast, our results showed that L-PAF-AH, which is again,
highly similar to the a1-subunit of PAF-AH isoform I with respect
to the primary amino acid sequences (Figure 1) and the simulated
3-D structure (unpublished data), could hydrolyze the 1-myristoyl-
2-(4-nitrophenylsuccinyl)-phosphatidylcholine (Table 1). Through
alignment of the primary amino acid sequences of L-PAF-AH with
the bovine PAF-AH isoform I a1-subunit, the putative corre-
sponding amino acid residues involved in this substrate specificity
was deduced as Leu
81, Ile
226 and Gly
132 in correspondence to the
Leu
48, Leu
194 and Thr
103 of the isoform I a1-subunit (Figure 1),
which was different from that either in the PAF-AH domain of the
E. coli CS or in the a1-subunit of PAF-AH isoform I. In
conclusion, the L-PAF-AH is a unifunctional PAF-AH enzyme
Figure 4. Time course of pulmonary hemorrhage (A), mortality rate (B) and PAF-AH level in serum (C) of gerbils inoculated with
PBS, the avirulent strain of L. interrogans serovar Lai and L. interrogans serovar Lai. PBS, injected with PBS alone; avirulent, injected with the
avirulent strain of L. interrogans serovar Lai; virulent, injected with L. interrogans serovar Lai. (A) The measurement and plot of pulmonary hemorrhage
referred to Materials and Methods. (C) Avirulent
a, no pulmonary hemorrhage observed in the gerbils injected with the avirulent strain of L. interrogans
serovar Lai; avirulent
b, pulmonary hemorrhage observed in the gerbils injected with the avirulent strain of L. interrogans serovar Lai. At indicated
time, number of animals was shown under the figures. Bar indicated the standard error.
doi:10.1371/journal.pone.0004181.g004
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that of the above mentioned E. coli PAF-AH domain or a1-subunit
of PAF-AH isoform I, probably due to the change of the conserved
substrate binding related amino acid residues.
We also proved that L-PAF-AH was an intracellular enzyme
conserved among all species of Leptospira, pathogenic or sapro-
phytic. The l-paf-ah gene is unanimously present in ten pathogenic
and saprophytic leptospires, and they were primarily expressed at
similar levels while culturing in EMJH or Korthof media detected
by RT-PCR (Table 2). The specific activities of these cultures were
also similar among pathogenic and saprophytic leptospires grew
under the same conditions (Table 2). These results implicated that
L-PAF-AH is involved in the physiological activities of leptospires.
Employing L-PAF-AH specific monoclonal and polyclonal
antibodies in combination, we were able to access the contribution
of L-PAF-AH in the total PAF-AH level in serum during
hemorrhage stage of severe leptospirosis in gerbil experimental
model. Although the PAF-AH activity in serum was elevated in the
experimental leptospirosis, the contribution of L-PAF-AH was
very low (estimated, 0.07%). On the other hand, it is still possible
that the L-PAF-AH released from autolysed leptospires during
mid- and late-phase of infection may function as a virulent factor
within the local niche of small blood capillaries of the alveoli [14]
as its substrate, PAF, a potent lipid messenger, participates in a
variety of physiological events including platelet aggregation to
maintain the blood homeostasis [25].
Recent reports suggested that serum PAF-AH might play an
anti-inflammatory role in human diseases, such as atherosclerosis
[26], asthma [27], and septic shock [28], by preventing the
accumulation of PAF and PAF-like oxidized phospholipids.
However, the simulation the role of serum PAF-AH in human
diseases in different animal-models provided controversial out-
comes even for the same disease. For instance, it was reported that
LPS increases serum PAF-AH activity in Syrian hamsters [29].
However, in the Swiss and C57BL6 mouse models of endotoxemia
administrated by LPS, serum activity of PAF-AH is significantly
decreased within 24 hr after the challenge and then returns to
baseline in surviving animals [30]. Thus, the nature of the animal
selected for in vivo investigation was found to markedly affect the
results. It would, therefore, be of interest to explore the suitable
animal to simulate the role of human serum PAF-AH.
The present study first investigated the serum PAF-AH levels of
the commonly used experimental rodent and rabbit species,
particularly guinea pig [13,31,32] and golden hamster [33], the
most common models for the leptospirosis studies and found that
only Mongolian gerbil has its normal serum PAF-AH level similar
to that of human (Figure 3A). Furthermore, the patterns of the
change of PAF-AH level in serum during the course of severe
leptospirosis were similar in gerbils and patients (Figure 5 and
Figure S6), including the levels of elevation. Therefore, gerbil
seems to be the best model animal among the rodent and rabbit
species to reflect the role of serum PAF-AH in the human diseases.
Platelet aggregation as well as platelet adhesion and subsequent
plug formation at the site of injury plays a major role in the control
of vascular hemostasis. Decreases in PAF levels in vivo, leading to
decreased ability of platelet aggregation, can profoundly influence
vascular hemostasis [25,34]. The acetyl group at the sn-2 position
of its glycerol backbone is essential for its biological activity, and its
deacetylation product, lyso-PAF, loses biological activity. Com-
paring PAF-AH to the control, its changes in serum were closely
associated with the whole course of pulmonary hemorrhage
(Figure 4B and 4C). In human, the PAF-AH levels in serum of
leptospirosis patients infected by L. interrogans of serogroup
Icterohaemorrhagiae were found significantly higher than that of
either normal control or patients infected by non-icterohaemor-
rhagiae leptospires (P,0.01) (Figure 5). These findings could be
directly related to the possible decrease of the blood platelet
activation activity of PAF caused by the elevated PAF-AH
catalyzed hydrolysis. Eventually, pulmonary hemorrhage happens,
of course, including the effects of the other virulent factors, such as
LPS. Thus, the PAF-AH in serum might play an important role in
the pulmonary symptom in severe leptospirosis although its
mechanism is yet to be learnt along with the confirmation of this
hypothesized function.
Practically, PAF-AH level in serum seems more likely a suitable
biochemical marker for monitoring the occurrence of the lethal
pulmonary hemorrhage in cases of severe leptospirosis. Most
human fatalities in leptospirosis are due to hemorrhage, and
pulmonary involvement is the main type of hemorrhage in the host
[1]. Clinical course of pulmonary hemorrhage has been known to
be developed so quickly that doctors did not have enough time to
Figure 5. PAF-AH levels in serum of patients with leptospirosis
and healthy adult individuals. Normal (n=15), healthy human
group; non-icterohaemorrhagiae (n=18), leptospirosis patients infected
by L. interrogans serogroup Pyrogenes (n=3), Autumnalis (n=3),
Pomona (n=3), Hebdomadis (n=4) and Canicola (n=5), other than L.
interrogans serogroup Icterohaemorrhagiae; icterohaemorrhagiae
(n=28), leptospirosis patients infected by L. interrogans serogroup
Icterohaemorrhagiae. Horizontal bars represented the mean value for
each group.
doi:10.1371/journal.pone.0004181.g005
Figure 6. Blood leptospira level of eight gerbils infected by L.
interrogans serovar Lai. 0 represented that leptospira was not
observed. Bar indicated the standard error.
doi:10.1371/journal.pone.0004181.g006
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most of the death for severe leptospirosis patients [1–3]. Thus,
the need for developing some convenient monitoring strategies
has become even more critical now. The significant direct
association of the PAF-AH activities in serum with the
pulmonary hemorrhage implied that it would be one biochem-
ical marker for monitoring the level of risk for pulmonary
hemorrhage development along the course of the disease, which
in turn, may direct the doctors to apply different therapeutic
strategies for individual patients suffered in different disease
phases to reduce the mortality rate of the severe leptospirosis. In
our opinion, suitable antibiotics application for different
duration of the disease with different PAF-AH level in serum
might be suggested to support the present existed standards, such
as doxycycline for both prophylaxis and mild disease [35,36],
ampicillin and amoxicillin for mild disease, whereas penicillin G
and ampicillin for severe disease [37]. Besides, because PAF-AH
is also considered a regulatory molecule for immune responses,
appropriate application of some immune modulation drugs at
certain duration of the severe leptospirosis might be considered,
at least for animal model analysis. Finally, some assistant
therapies, such as hospital admission and close observation,
should be required for the severe patients at their early stage of
the disease course. Thus, our observations have provided a
potential clinical molecular marker for prospective clinical
evaluation, by which, the manifestation course leading to
pulmonary hemorrhage might be monitored to reduce the
mortality of the severe leptospirosis.
To our knowledge, it is the first time that increased PAF-AH
level in serum was reported for sepsis. Graham et al. reported
decreased PAF-AH serum activity in blood samples from septic
patients and the half-life of PAF was prolonged in the serum of
dying septic patients compared to survivors or normal volunteers
[38]. Furthermore, in mouse models, serum activity of PAF-AH is
significantly decreased within 24 hr after the challenge and then
returns to baseline in surviving animals [30]. As leptospirosis shows
typical sepsis symptoms including chills, headache, myalgia,
abdominal pain, conjunctival suffusion, and less often a skin rash
[39], it was surprising to observe the elevation of PAF-AH in
serum in severe leptospirosis patients (Figure 5) and gerbil models
(Figure 4C). In addition, the PAF-AH levels in serum of dying
gerbils, most of which showed the severest pulmonary hemor-
rhage, were significant higher than the mean level of total gerbils
infected the virulent strain (Figure S6). Considering that
leptospires are different from either Gram-positive or Gram-
negative bacteria with basically unknown mechanisms of patho-
genicity or virulence [1], the modulation of PAF-AH in serum
might be different between the leptospirosis patients vs. other sepsis
patients, for most of them were infected by typical Gram-positive
or Gram-negative pathogenic bacteria [30,38]. Thus, this
changing pattern of PAF-AH in serum, so-far unique for severe
leptospirosis may distinguish it from other reported sepses [30,38],
which may eventually help us to further understand the
pathogenesis of leptospirosis. Moreover, as different sepses may
have different response of PAF-AH activity, the exact role of
serum PAF-AH in different kinds of sepses must be answered
before undertaking any related medication, i.e. administration of
recombinant serum PAF-AH [40,41].
Intracellular isoforms of PAF-AH exist and are found in liver,
kidney and brain [42]—tissues involved in leptospiral complica-
tions and multiple organ failure [1]. It is possible that not all of
the activities measured in the blood of patients and gerbils with
leptospirosis were from the secreted, extracellular form of PAF-
AH—the resident enzyme of normal serum—but also included
intracellular activity that leaked from injured or dying cells.
Therefore, one of our next challenges would be to identify
which isoform of the host PAF-AH actually makes the
major contribution of elevation and explore the elevation
mechanism.
Materials and Methods
Bacterial strains, media, and growth conditions
The avirulent strain of L. interrogans serovar Lai was kindly
provided by Professor Isabelle Saint Girons (Unite ´ de Bacte ´r-
iologie Mole ´culaire et Me ´dicale, Institut Pasteur, France). L.
interrogans serovar Lai strain 56601 and other leptospiral strains
(Table 2) used in this study are maintained by the National
Institute for Communicable Disease Control and Prevention,
Chinese Center for Disease Control and Prevention, China.
Leptospires were cultivated in liquid EMJH or Korthof [39]
medium at 28uC under aerobic conditions, and the bacterial cell
density of the culture was counted in a Petroff-Hausser counting
chamber (Fisher). Only the mid-log phase cells were used for
experiments.
E. coli strains DH5a and BL21 (DE3) pLysS (Novagen) were
used for heterogeneous gene cloning and expression, respectively.
They were routinely propagated at 37uC in LB medium [43].
Growth medium was supplemented with 100 mg/ml ampicillin or
50 mg/ml kanamycin when required.
Bioinformatic analysis
Sequence similarity search was performed using the program
BLAST. The multiple alignment of amino acid sequences was
performed by ClustalW. The signal peptide was predicted by
SignalP 3.0.
Recombinant plasmid construction, protein expression
and purification
L. interrogans gene l-paf-ah was synthesized by PCR with strain
56601 or serovar Canicola strain Lin genomic DNAs as the
templates (Table 2). PCR primers were designed as following:
forward, 59-CATATGTTGATTAAGAAATCATATACG-39; re-
verse, 59-TTAAAGATAGGGTAAAAGTATCGGT-39. The de-
sired gene fragment was cloned into pET-28b, and confirmed by
DNA sequencing. Protein expression was induced by 0.4 mM
isopropyl-D-thiogalactopyranoside at 28uC for 4 hr when A600
values reached 0.6–0.8. Protein purification was applied to Ni-
NTA column. Protein concentration was determined by the
bicinchoninic acid method, with bovine serum albumin as the
standard.
Enzyme activity assay
Measurement of PAF-AH activity was performed as described
[21] employing the Azwell Auto PAF-AH kit (Azwell): PAF-AH
hydrolyzes the sn-2 position of the substrate [1-myristoyl-2-(4-
nitrophenyl succinyl) phosphatidylcholine], a PAF (1-alkyl-2-acetyl
phosphatidylcholine/1-O-alkyl-2-acetyl-sn-glycero-3-phospholine)
analogue with a 4-nitrophenyl substituent, resulting in generating
4-nitrophenyl succinate, which is immediately degraded to 4-
nitrophenol and subsequently measured spectrophotometrically at
405 nm. The activity is expressed in IU/L; 1 IU of PAF-AH
hydrolyses 1 mmol of substrate in 1 min. The enzyme kinetics data
were collected employing the purified rL-PAF-AH while human
serum samples were used for the Km determination of human
serum PAF-AH.
Marker of Pulmonary Hemorrhage
PLoS ONE | www.plosone.org 8 January 2009 | Volume 4 | Issue 1 | e4181Production of anti-L-PAF-AH rabbit polyclonal serum and
murine monoclonal antibodies (MoAbs)
New Zealand rabbits were immunized with rL-PAF-AH. Equal
amounts of adjuvant and antigen solution were mixed thoroughly
for each inoculation. Subcutaneous injections of 200 mg of antigen
per rabbit were carried out. First immunizations were done with
complete Freund’s adjuvant (Invitrogen) and subsequent immuni-
zations were done employing incomplete Freund’s adjuvant
(Invitrogen) on days 14, 28 and 35. Rabbits were bled on the 1st
or 2nd weeks after the last booster.
BALB/c mice were immunized intraperitoneally with purified
rL-PAF-AH as previously reported [44]. The generated hybrid-
oma cells were screened for antibody production by ELISA using
microtiter plates coated with rL-PAF-AH. Positive hybridomas
without reactivity against gerbil serum were selected, and injected
into the pristane-primed BALB/c mice. After 3 weeks, ascitic fluid
was collected and stored at 220uC. Murine MoAbs were purified
from ascitic fluid on protein A-Sepharose 4B. The specificity of
antibody-antigen interaction distinguishing the L-PAF-AH and the
gerbil serum PAF-AH was further tested with ELISA.
Antigen-capture ELISA
Antigen-capture ELISA was performed by following standard
protocol described elsewhere in detail [45]. Anti-L-PAF-AH
murine MoAb and rabbit polyclonal antibody were used as
capture and detection antibodies for the L-PAF-AH, respectively.
Immunoprecipitation and protein identification by mass
spectrometry
Cell extract (1 ml), or culture supernatant (4 ml) of L. interrogans
serovar Lai strain 56601, or serum (500 ml) were mixed with 5 ml
of rabbit polyclonal serum rotating at 4uC for 2 hr, and incubated
for 1 hr with 20 ml of protein A-Sepharose. Beads were washed
(50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton
X-100, 1 mM PMSF, 10 mg/ml Aprotinin and 10 mg/ml
Leupeptin), and bound protein was eluted with Laemmli sample
buffer and separated by SDS-PAGE. The approximate 20 kDa to
30 kDa band was incised, digested by trypsin, and identified by
mass spectrometry shotgun analysis as described previously [46].
Nine peptides, some of which were overlapped, were identified
through mass spectrometry shotgun analysis. Although the
predicted signal peptide was not identified, the authenticity of
the protein precipitated was confirmed.
Animal study
Male mice (ICR, BALB/c, CBA/N, C57BL/6, DBA/2, and
C3H/HeJ), rats (Fischer 344, Sprague-Dawley, and Wistar),
golden hamster, guinea pig, Mongolian gerbil, and New Zealand
rabbit, one to two months of age, were from Shanghai Laboratory
Animal Center, China. Blood was collected by cardiac puncture,
and serum PAF-AH level was detected to screen potential
experimental animal.
Male Mongolian gerbils, two months of age, were used in the
leptospira infection experiment. To exclude the effect of EMJH
medium, spirochetes grown in EMJH medium were pelleted by
centrifugation, resuspended in 0.01 M phosphate-buffered saline
(PBS), repelleted, and washed twice in PBS. Gerbils were injected
intraperitoneally with 1 ml PBS alone (negative control), PBS with
the avirulent strain of L. interrogans serovar Lai (5610
8) and PBS
with L. interrogans serovar Lai (5610
8). The animal study design
was shown in Figure S3. Seven gerbils in each group were not
euthanized until to the 9
th day after infection, and blood was
collected from the tail. The other gerbils in each group were
euthanized on the 1
st,2
nd,3
rd,4
th,5
th,6
th,7
th,8
th and 9
th day after
infection, and blood was collected by cardiac puncture. All animal
studies were approved by the Animal Research Committee of the
Chinese National Human Genome Center at Shanghai.
Measurement of pulmonary hemorrhage
The pulmonary hemorrhage was observed and measured as
previously described [47] with slight modifications. The scores of
0, 1, 2 and 3 were defined to illustrate the level of severeness of the
manifestation as absence of pulmonary hemorrhage, hemorrhagic
focus (minimal), hemorrhagic area (moderate) and hemorrhagic
diffusion (marked), respectively.
Blood concentration of leptospires
Approximately 0.2 ml of blood was taken via the tail, and was
left to stand in a heparinized Dreyer agglutination tube until the
erythrocytes had settled sufficiently (10 min) to allow the
leptospires in a drop of the supernatant to be counted in a
Petroff-Hausser counting chamber (Fisher).
Nucleotide sequence accession numbers
The nucleotide sequences of the l-paf-ahs and the corresponding
upstream regions from nine leptospira strains were deposited in
GenBank. The accession numbers are EF191070 for the avirulent
strain of L. interrogans serovar Lai, EF191073 for L. interrogans
serovar Javanica strain M 10, EF191069 for L. interrogans serovar
Canicola strain Lin, EF191074 for L. interrogans serovar Pomona
strain Luo, EF191071 for L. interrogans serovar Linhai strain Lin 6,
EF191072 for L. interrogans serovar Hebdomadis strain P 7,
EF191066 for L. interrogans serovar Paidjan strain L 37, EF191068
for L. biflexa serovar Montevalerio, and EF191067 for L. biflexa
serovar Anhui strain Zong 7.
RT-PCR
Total RNA from mid-log phase leptospires cultured in EMJH or
Korthof medium (Table 2) was extracted by using Trizol Reagent
(Invitrogen). RNase-free DNase-treated RNA was hybridized to
random hexamer primers, and cDNA was synthesized with AMV
reverse transcriptase as specified by the manufacturer (Promega).
The cDNA was amplified with Taq DNA polymerase (Takara) with
gene-specific primer pair. The primers were the same as the pair of
primers used for recombinant l-paf-ah plasmid construction.
Patients and control individuals
Serum samples were collected in 2008 from 46 patients with
confirmed leptospirosis from Anhui Center for Disease Control
and Prevention, China. Diagnosis was confirmed by the micro-
agglutination test (MAT) with the following criteria: a four-fold or
greater rise in titer between paired serum samples; seroconversion
(initial MAT titer of ,100 increasing to $200); or a single serum
titer $400 were considered positive. Among the 46 leptospirosis
patients, 28 patients were infected by L. interrogans serogroup
Icterohaemorrhagiae. The other 18 patients were infected by L.
interrogans serogroup Pyrogenes (n=3), Autumnalis (n=3), Po-
mona (n=3), Hebdomadis (n=4) and Canicola (n=5). Control
serum samples were collected from 15 healthy individuals. Written
informed consent was obtained from each participant prior to the
collection of blood according to protocols approved by the
Chinese National Human Genome Center at Shanghai.
Ethics statement
This human study was conducted according to the principles
expressed in the Declaration of Helsinki. Written informed
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of blood according to protocols approved by the Chinese National
Human Genome Center at Shanghai.
All animals were handled in strict accordance with good animal
practice as defined by the relevant local animal welfare bodies, and
all animal work was approved by the Animal Research Committee
of the Chinese National Human Genome Center at Shanghai.
Statistics
Data were analyzed with Graph-Pad Prism, version 2.0
(GraphPad Software). Data were presented as mean values6SEM.
Statistical analyses were performed using one way analysis of
variance (ANOVA).
Supporting Information
Figure S1 Purification of His-Tag fusion protein L-PAF-AH in
the E. coli BL21 (DE3) pLysS cells monitored with the 15% SDS-
PAGE. Lane 1, protein purified with Ni-NTA column from the
soluble fraction in the bacterial lysate; lane 2, the molecular weight
markers. Gel was stained with silver staining.
Found at: doi:10.1371/journal.pone.0004181.s001 (1.50 MB TIF)
Figure S2 DNA-sequence similarity comparison of l-paf-ah from
L. interrogans serovar Lai strain 56601 (la2144) with that from the
avirulent strain of L. interrogans serovar Lai (Avirulent Lai), L.
interrogans serovar Javanica strain M 10 (Javanica), L. biflexa
serovar Montevalerio (Montevalerio), L. interrogans serovar
Linhai strain Lin 6 (Linhai), L. interrogans serovar Paidjan strain
L 37 (Paidjan), L. interrogans serovar Pomona strain Luo
(Pomona), L. interrogans serovar Hebdomadis strain P 7
(Hebdomadis), L. biflexa serovar Anhui strain Zong 7 (Anhui),
L. interrogans serovar Canicola strain Lin (Canicola).
Found at: doi:10.1371/journal.pone.0004181.s002 (8.36 MB TIF)
Figure S3 Study design in gerbil leptospirosis model.
Found at: doi:10.1371/journal.pone.0004181.s003 (3.53 MB TIF)
Figure S4 PCR assay detection of leptospira on the 4th day in
lung, heart, kidney, spleen and liver of gerbils inoculated with PBS,
the avirulent strain of L. interrogans serovar Lai and L.
interrogans serovar Lai. Lane 1, injected with PBS alone; lane 2,
injected with the avirulent strain of L. interrogans serovar Lai; lane
3, injected with L. interrogans serovar Lai; lane M, DNA
molecular size marker.
Found at: doi:10.1371/journal.pone.0004181.s004 (0.92 MB TIF)
Figure S5 Time-course of L-PAF-AH in the sera of gerbils
injected with the virulent strain. The measurements were
performed on the 2nd, 3rd, 4th, 5th, 6th, 7th, 8th and 9th days
via both ELISA and immunoprecipation followed by mass
spectrometric identification. The EMJH culture supernatant of
leptospira obtained in the later stationary phase was used as the
positive controls. X, L-PAF-AH detected by ELISA; e, L-PAF-
AH undetectable by ELISA; w, L-PAF-AH detected by
immunoprecipation followed by mass spectrometry; q, L-PAF-
AH undetectable by immunoprecipation followed by mass
spectrometry. The standard error of the experiments was indicated
by bars.
Found at: doi:10.1371/journal.pone.0004181.s005 (0.19 MB TIF)
Figure S6 PAF-AH levels in serum from the 1st to 9th day in
gerbils with experimentally infected leptospirosis and in healthy
gerbils. PBS (n=107), injected with PBS alone; avirulent (n=106),
injected with the avirulent strain of L. interrogans serovar Lai;
virulent (Total) (n=136), injected with L. interrogans serovar Lai,
including the serum of the gerbils which were dying and 5 hr
before dying; virulent (Dying) (n=56), injected with PBS with L.
interrogans serovar Lai, and collected from the gerbils which were
dying and 1 hr before dying. Horizontal bars represented the
mean value for each group.
Found at: doi:10.1371/journal.pone.0004181.s006 (0.23 MB TIF)
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